Cardiocomm Solutions (TSE:EKG) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CardioComm Solutions has received Health Canada clearance for its GEMS™ Rhythm AI software, enhancing its ECG monitoring solutions with the automated detection of multiple cardiac arrhythmias and abnormalities. The technology is pivotal for the company’s roadmap, aiming to integrate it with various ECG monitoring products for flexible and comprehensive patient care. With this advancement, CardioComm strengthens its product lineup, which includes home ECG devices and multi-signal monitoring solutions.
For further insights into TSE:EKG stock, check out TipRanks’ Stock Analysis page.